Expression of the novel tumour suppressor p33ING1 is independent of p53

被引:0
|
作者
K-J J Cheung
J A Bush
W Jia
G Li
机构
[1] Department of Medicine,Department of Surgery
[2] Division of Dermatology,undefined
[3] University of British Columbia and Vancouver Hospital and Sciences Centre,undefined
来源
British Journal of Cancer | 2000年 / 83卷
关键词
in vivo expression; tumour suppressor gene; UV irradiation;
D O I
暂无
中图分类号
学科分类号
摘要
A recently cloned tumour suppressor candidate, p33ING1, has been shown in vitro to collaborate with p53 to execute growth arrest and apoptosis. However, it is unclear as to how the expression of ING1 is regulated in normal and stress conditions. Using a p53-knockout mouse model, we investigated if the expression of ING1 was dependent on p53. We found that there was no difference in ING1 mRNA and protein levels between p53+/+ and p53–/– murine organs. In addition, when normal human epithelial keratinocytes (NHEK) and a keratinocyte cell line, HaCaT, which lacks wild-type p53 function, were exposed to UVB irradiation, the expression levels of ING1 were elevated in both NHEK and HaCaT cells. It is interesting, however, that UVB irradiation did not induce ING1 expression in dermal fibroblasts isolated from p53+/+ and p53–/– mice. Based on our findings, we therefore conclude that the expression of ING1 is independent of p53 status. UV induction of ING1 in keratinocytes suggests that ING1 may play a role in cellular stress response and skin carcinogenesis. © 2000 Cancer Research Campaign http://www.bjcancer.com
引用
收藏
页码:1468 / 1472
页数:4
相关论文
共 50 条
  • [21] Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
    A Tannapfel
    K Engeland
    L Weinans
    A Katalinic
    J Hauss
    J Mössner
    Ch Wittekind
    British Journal of Cancer, 1999, 80 : 1069 - 1074
  • [22] 胃癌组织中p33ING1、p53基因蛋白的表达及其临床意义
    丁厚中
    杨海人
    李海
    蔡晓凤
    李良波
    李才华昆山市第一人民医院普外科
    吴晓阳
    杨栋
    冷新
    倪灿荣
    朱明华
    苏州医学院学报, 2001, (01) : 55 - 58
  • [23] The p53 tumour suppressor protein
    Hickman, ES
    Helin, K
    BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL 17, 2000, 17 : 179 - 211
  • [24] The p53 tumour suppressor gene
    Steele, RJC
    Thompson, AM
    Hall, PA
    Lane, DP
    BRITISH JOURNAL OF SURGERY, 1998, 85 (11) : 1460 - 1467
  • [25] The expression of p33ING1, p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer
    Liu, Jun
    Lin, Yongping
    Yang, Haihong
    Deng, Qiuhua
    Chen, Guoqin
    He, Jianxing
    TUMOR BIOLOGY, 2011, 32 (06) : 1113 - 1121
  • [26] The p53 tumour suppressor protein
    Hickman, E.S.
    Helin, K.
    Biotechnology and Genetic Engineering Reviews, 2000, 17 : 179 - 211
  • [27] 食管癌中p33ING1 p53蛋白的表达及临床意义
    罗荣
    黄克峰
    陈德荣
    战忠利
    中国肿瘤临床, 2009, 36 (06) : 324 - 327
  • [28] Dysfunction of p53 pathway in human colorectal cancer: Analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2
    Tachibana, M
    Kawamata, H
    Fujimori, T
    Omotehara, F
    Horiuchi, H
    Ohkura, Y
    Igarashi, S
    Kotake, K
    Kubota, K
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (04) : 913 - 920
  • [29] p33ING1b tumour suppressor immunohistochemical expression in invasive breast carcinomas
    Nouman, GS
    Anderson, JJ
    Crosier, S
    Shrimankar, J
    Lunec, J
    Angus, B
    JOURNAL OF PATHOLOGY, 2002, 198 : 30A - 30A
  • [30] p53 Tumour suppressor gene expression in pancreatic neuroendocrine tumour cells
    Bartz, C
    Ziske, C
    Wiedenmann, B
    Moelling, K
    GUT, 1996, 38 (03) : 403 - 409